JDRF T1D Fund — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Biopharmaceutical gene therapy company developing gene therapies intended to be accessible broadly rather than to a limited few.
BiotechMorrisville, US
Ilan Oren(Director)Shankar Ramaswamy(Executive Officer, Director)Michele Stone(Executive Officer)Katherine Eade(Executive Officer)Britt Petty(Executive Officer)Daniel Chen(Executive Officer)
Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Fan Yu(Director)Maggie Wilderotter(Director)Toni Hoover(Director)Terry Rosen(Director)Richard Klausner(Director)Jeffrey Bluestone(Executive Officer, Director, Promoter)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.